Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.
dc.contributor.author | Gaipov, Abduzhappar | |
dc.contributor.author | Myngbay, Askhat | |
dc.date.accessioned | 2020-05-19T10:40:53Z | |
dc.date.available | 2020-05-19T10:40:53Z | |
dc.date.issued | 2018-01 | |
dc.identifier.citation | Gaipov, A., & Myngbay, A. (2018). Stem Cells Therapy in General Medicine. Electronic Journal of General Medicine, 15(2). https://doi.org/10.29333/ejgm/83014 | en_US |
dc.identifier.issn | 2516-3507 | |
dc.identifier.other | 10.29333/ejgm/83014 | |
dc.identifier.uri | https://www.ejgm.co.uk/article/stem-cells-therapy-in-general-medicine-7406 | |
dc.identifier.uri | https://doi.org/10.29333/ejgm/83014 | |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/4730 | |
dc.description.abstract | Regenerative medicine is much of intense interest among scientists and clinicians. This is a comparatively new field and needs further developments in use. To date, more than 355K in PubMed and almost 3M in Google Scholar, different articles, studies, protocols, and reports related to stem cells indexed and published. In this editorial, we briefly explored the current status and the perspectives of stem cell therapy in general medicine. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | Electronic Journal of General Medicine;Volume 15 Issue 2, Article No: em01 | |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.subject | Stem Cells Therapy | en_US |
dc.subject | HLA-incompatible donors | en_US |
dc.subject | immunogenicity | en_US |
dc.subject | Research Subject Categories::MEDICINE | en_US |
dc.title | Stem Cells Therapy in General Medicine | en_US |
dc.type | Article | en_US |
workflow.import.source | science |
The following license files are associated with this item: